VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity

Biochem Biophys Res Commun. 2022 Nov 5:628:18-24. doi: 10.1016/j.bbrc.2022.08.055. Epub 2022 Aug 24.

Abstract

VSIG4, a newly identified co-inhibitory molecule belonging to the B7-related family, is exclusively expressed on tissue-resident macrophages and is involved in the suppression of T cell proliferation and cytokine production. We sought to characterize the role of VSIG4 in anti-tumor immunity in the tumor microenvironment, focusing on VSIG4-expressing tumor-associated macrophages (TAMs). We found that VSIG4-expressing TAMs negatively regulated antigen-specific T cell proliferation and cytokine production through direct inhibition via cell cycle arrest, but not apoptosis, as well as through their arginase 1 activity. Furthermore, VSIG4-expressing TAMs suppress tumor-specific CD8+ T cell cytotoxicity. Therefore, our results suggest that VSIG4-expressing TAMs could be a negative cellular regulator of anti-tumor immunity in the tumor microenvironment.

Keywords: Anti-tumor T cell immunity; Tumor microenvironment; Tumor-associated macrophages; VSIG4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginase / genetics
  • Arginase / metabolism
  • Cytokines / metabolism
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Receptors, Complement* / metabolism
  • Tumor Microenvironment* / immunology
  • Tumor-Associated Macrophages* / immunology
  • Tumor-Associated Macrophages* / metabolism

Substances

  • Cytokines
  • Receptors, Complement
  • VSIG4 protein, mouse
  • Arginase